Print ISSN:-2581-5555

Online ISSN:-2456-9542

CODEN : IIJCDU

Article History

Received : 14-03-2024

Accepted : 21-05-2024



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 230

PDF Downloaded: 93


Critical review on analytical detection of first line and second line anti tubercular agent by various modern analytical method


Full Text PDF Share on Facebook Share on Twitter


Review Article

Author Details : TS Basuri*, Ranjit Mohapatra

Volume : 9, Issue : 2, Year : 2024

Article Page : 91-97

https://doi.org/10.18231/j.ijcaap.2024.014



Suggest article by email

Get Permission

Abstract

Tuberculosis is a chronic inflammatory, granulomatous bacterial infectious disease caused by Mycobacterium tuberculosis. About 10 million people worldwide are ill with MTB in 2018, 5.7 million are males, 3.2 million are females and 1.1 million are infants, 1.6 million died from the disease. This article includes epidemiology, classification, pathogenesis, diagnosis and treatment of Tuberculosis. It includes the drug profile of antitubercular agents such as isoniazid, pyrazinamide, ethambutol, rifampicin, paraminosalicylic acid, thiacetazone, ethionamide, kanamycin, amikacin. cycloserine, viomycin, morphazinamide and some newer drugs such as ofloxacin, ciprofloxacin, clarithromycin and rifabutin. It contains analytical detection methods of antitubercular agents by HPLC.


Keywords: Tuberculosis, First line agents, Second line agents, Analytical detection, HPLC



How to cite : Basuri T, Mohapatra R, Critical review on analytical detection of first line and second line anti tubercular agent by various modern analytical method. IP Int J Compr Adv Pharmacol 2024;9(2):91-97


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.